Ralf Altmeyer
Impact in
- Infectious Diseases top 0.5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
- Viral Infections and Vectors
- Virology top 1%
- HIV Research and Treatment
Papers in
-
- Viral gastroenteritis research and epidemiology 9
- SARS-CoV-2 and COVID-19 Research 5
-
- Viral Infections and Immunology Research 19
- Co-authors
- Fernando Arenzana‐Seisdedos (8 shared papers)Jean‐Louis Virelizier (6 shared papers)Ali Amara (5 shared papers)Béatrice Nal (8 shared papers)Roberto Bruzzone (8 shared papers)Olivier Schwartz (3 shared papers)François Kien (6 shared papers)Malik Peiris (7 shared papers)
In The Last Decade
Ralf Altmeyer
58 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 116
- Infectious Diseases 1.9k
- Virology 412
- Hepatology 277
- Immunology 720
- Animal Science and Zoology 341
Countries citing papers authored by Ralf Altmeyer
This map shows the geographic impact of Ralf Altmeyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Altmeyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Altmeyer more than expected).
Fields of papers citing papers by Ralf Altmeyer
This network shows the impact of papers produced by Ralf Altmeyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Altmeyer. The network helps show where Ralf Altmeyer may publish in the future.
Co-authors
The 25 scholars most cited alongside Ralf Altmeyer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 422 | |
| 2 | 2008 | 380 | |
| 3 | 2003 | 319 | |
| 4 | 2011 | 228 | |
| 5 | 2005 | 190 | |
| 6 | 2006 | 161 | |
| 7 | 2004 | 160 | |
| 8 | 2021 | 158 | |
| 9 | 2002 | 129 | |
| 10 | 2009 | 123 | |
| 11 | 2003 | 95 | |
| 12 | 1993 | 92 | |
| 13 | 2012 | 80 | |
| 14 | 2007 | 75 | |
| 15 | 2007 | 71 | |
| 16 | SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement. | 2012 | 69 |
| 17 | 2015 | 66 | |
| 18 | 2001 | 63 | |
| 19 | 2009 | 61 | |
| 20 | 2015 | 59 |
About Ralf Altmeyer
Ralf Altmeyer is a scholar working on Infectious Diseases, Cardiology and Cardiovascular Medicine, Epidemiology, Virology and Molecular Biology, having authored 58 papers that have together received 4.0k indexed citations. Recurring topics across this work include Viral Infections and Immunology Research (19 papers), HIV Research and Treatment (12 papers), Respiratory viral infections research (11 papers), Viral gastroenteritis research and epidemiology (9 papers), Animal Disease Management and Epidemiology (8 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Influenza Virus Research Studies (4 papers). The work is most often cited by research in Infectious Diseases (1.9k citations), Virology (412 citations), Hepatology (277 citations), Immunology (720 citations) and Animal Science and Zoology (341 citations). Ralf Altmeyer has collaborated with scholars based in France, China and Hong Kong. Frequent co-authors include Fernando Arenzana‐Seisdedos, Jean‐Louis Virelizier, Ali Amara, Béatrice Nal, Roberto Bruzzone, Olivier Schwartz, François Kien, Malik Peiris, Nicolas Escriou and Pierre‐Yves Lozach. Their work appears in journals such as Journal of Virology, PLoS ONE, Journal of Biological Chemistry, Antiviral Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.